Trupanion (TRUP) Upgraded at BidaskClub

BidaskClub upgraded shares of Trupanion (NASDAQ:TRUP) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning.

TRUP has been the topic of a number of other research reports. Zacks Investment Research upgraded Trupanion from a sell rating to a hold rating and set a $42.00 target price on the stock in a report on Tuesday, August 7th. Craig Hallum began coverage on Trupanion in a report on Thursday, July 19th. They set a buy rating and a $55.00 target price on the stock. Cowen upped their target price on Trupanion from $41.00 to $47.00 and gave the stock a positive rating in a report on Friday, August 3rd. Raymond James initiated coverage on Trupanion in a research note on Thursday, September 6th. They issued an outperform rating and a $46.00 price target on the stock. Finally, Royal Bank of Canada upped their price target on Trupanion to $44.00 and gave the stock an outperform rating in a research note on Friday, August 3rd. Three analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Trupanion currently has a consensus rating of Buy and a consensus price target of $45.22.

TRUP stock opened at $32.43 on Wednesday. Trupanion has a fifty-two week low of $25.42 and a fifty-two week high of $46.70. The company has a current ratio of 3.04, a quick ratio of 3.04 and a debt-to-equity ratio of 0.16. The company has a market cap of $1.18 billion, a price-to-earnings ratio of -463.29 and a beta of 0.58.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, August 2nd. The financial services provider reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.04. Trupanion had a negative return on equity of 4.43% and a negative net margin of 0.84%. The firm had revenue of $73.39 million for the quarter, compared to the consensus estimate of $72.70 million. During the same quarter in the prior year, the business earned ($0.02) EPS. The business’s revenue for the quarter was up 25.9% on a year-over-year basis. analysts expect that Trupanion will post -0.08 EPS for the current year.

In related news, Director Murray B. Low sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $38.12, for a total value of $114,360.00. Following the transaction, the director now directly owns 189,782 shares of the company’s stock, valued at approximately $7,234,489.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Darryl Rawlings sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, July 23rd. The shares were sold at an average price of $45.72, for a total value of $182,880.00. The disclosure for this sale can be found here. Insiders sold a total of 23,450 shares of company stock worth $908,039 over the last ninety days. 20.70% of the stock is currently owned by insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Northern Trust Corp lifted its position in Trupanion by 27.2% in the 2nd quarter. Northern Trust Corp now owns 313,819 shares of the financial services provider’s stock valued at $12,114,000 after acquiring an additional 67,143 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Trupanion by 3.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 84,145 shares of the financial services provider’s stock valued at $3,248,000 after acquiring an additional 2,967 shares in the last quarter. Atlantic Trust LLC bought a new position in Trupanion in the 2nd quarter valued at approximately $251,000. WINTON GROUP Ltd bought a new position in Trupanion in the 2nd quarter valued at approximately $398,000. Finally, Macquarie Group Ltd. bought a new position in shares of Trupanion during the 2nd quarter valued at $1,405,000. 93.92% of the stock is currently owned by institutional investors and hedge funds.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Featured Story: The Role of a Fiduciary and Individual Investors

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply